Table 1.

Demographic and HIV-related data of the study population

Number of patients (n)	86
Gender (male:female)	71:15
Median age (years)	49 (range 19–72)
Median duration of HIV-infection (years)	13 (range 1–27)
cART (%)	89
Median CD4+ cell/μL	552 (range 3–1327)
Median CD8+ cell/μL	898 (range 70–2431)
Median T4/T8 ratio (PB)	0.6 (range 0.1–2.8)
Patients with T4/T8 ratio >1 PB (%)	25.6
Median HIV RNA copies/mL (PB)	nnw (range 0–135.000)
Median HIV RNA copies/mL (L)	nnw (range 0–418.000)
Patients with HI VL <37 copies/mL PB (%)	69.8 (26/86)
Patients with HI VL <37 copies/mL L (%)	75.6 (21/86)

HAND classification	Number of patients (n)	Controlled VL PB (%)	Controlled VL CSF (%)
Grade 0	11	81.8 (09/11)	90.9 (10/11)
Grade 1	25	76.0 (19/25)	63.6 (07/11)
Grade 2	37	64.9 (24/37)	64.9 (24/37)
Grade 3	13	61.5 (08/13)	76.9 (10/13)

PB, peripheral blood; VL, virus load; HAND, HIV-associated neurocognitive disorders; CSF, cerebrospinal fluid.